HLA-B38 AND CLOZAPINE-INDUCED AGRANULOCYTOSIS

被引：10
|
作者：
JOSEPH, G
NGUYEN, V
SMITH, JD
机构：
来源：
ANNALS OF INTERNAL MEDICINE | 1992年 / 116卷 / 07期
关键词：
D O I：
10.7326/0003-4819-116-7-605_1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：605 / 605
页数：1
相关论文
共 50 条
  • [21] Clozapine-induced agranulocytosis: Australian findings
    Reactions Weekly, 1998, 704 (1) : 4 - 4
  • [22] PLASMA CLOZAPINE AND DESMETHYLCLOZAPINE LEVELS IN CLOZAPINE-INDUCED AGRANULOCYTOSIS
    HASEGAWA, M
    COLA, PA
    MELTZER, HY
    NEUROPSYCHOPHARMACOLOGY, 1994, 11 (01) : 45 - 47
  • [23] Olanzapine: Safe during clozapine-induced agranulocytosis
    Oyewumi, LK
    Al-Semaan, Y
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (02) : 279 - 281
  • [24] Clozapine-induced agranulocytosis/granulocytopenia: mechanisms and monitoring
    Wicinski, Michal
    Weclewicz, Mateusz M.
    CURRENT OPINION IN HEMATOLOGY, 2018, 25 (01) : 22 - 28
  • [25] Sudden late onset of clozapine-induced agranulocytosis
    Patel, NC
    Dorson, PG
    Bettinger, TL
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (06) : 1012 - 1015
  • [26] Clozapine-induced agranulocytosis risk higher in Asians
    Reactions Weekly, 2000, 790 (1) : 5 - 5
  • [27] Clozapine-induced agranulocytosis and its genetic determinants
    Opgen-Rhein, Carolin
    Dettling, Michael
    PHARMACOGENOMICS, 2008, 9 (08) : 1101 - 1111
  • [28] Clozapine-induced concordant agranulocytosis in monozygotic twins
    Horácek, J
    Libiger, J
    Höschl, C
    Borzová, K
    Hendrychová, I
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2001, 5 (01) : 71 - 73
  • [29] CLUSTERING OF CLOZAPINE-INDUCED AGRANULOCYTOSIS IN EASTERN SWITZERLAND
    JUNGI, WF
    FISCHER, J
    SENN, HJ
    HARTLAPP, J
    POLDINGER, W
    KUNZ, H
    KRUPP, P
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1977, 107 (49) : 1861 - 1864
  • [30] The cytotoxicity of clozapine metabolites: Implications for predicting clozapine-induced agranulocytosis
    Tschen, AC
    Rieder, MJ
    Oyewumi, LK
    Freeman, DJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (05) : 526 - 532
12345